Compare SOPA & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SOPA | COCH |
|---|---|---|
| Founded | 2018 | 1995 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Blank Checks |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.0M | 24.4M |
| IPO Year | 2021 | N/A |
| Metric | SOPA | COCH |
|---|---|---|
| Price | $2.22 | $0.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $22.50 | $9.50 |
| AVG Volume (30 Days) | ★ 15.0M | 125.5K |
| Earning Date | 11-14-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,227,427.00 | $208,000.00 |
| Revenue This Year | $2.43 | N/A |
| Revenue Next Year | $71.20 | $25.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 4.65 | N/A |
| 52 Week Low | $0.64 | $0.64 |
| 52 Week High | $6.75 | $1.91 |
| Indicator | SOPA | COCH |
|---|---|---|
| Relative Strength Index (RSI) | 48.34 | 42.95 |
| Support Level | $2.12 | $0.64 |
| Resistance Level | $2.78 | $0.70 |
| Average True Range (ATR) | 0.30 | 0.03 |
| MACD | -0.09 | 0.00 |
| Stochastic Oscillator | 8.05 | 29.00 |
Society Pass Inc is building an ecosystem of platforms and technology-enabled companies that synergistically work together to transform how consumers and merchants interact with one another in Southeast Asia and South Asia. Through the acquisition of companies and partnerships with entrepreneurs, the company meets the growing demand for services in sectors such as lifestyle, beauty, travel, and food and beverage. The company currently operates in Six reportable operating segments: Online Grocery and Food deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-commerce, and Corporate. The company generates the majority of its revenue from the Digital marketing segment.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.